Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00AKV
|
|||
Former ID |
DIB000211
|
|||
Drug Name |
F-351
|
|||
Synonyms |
Liver cirrhosis, Gene Networks International; Liver cirrhosis, Shanghai; Liver fibrosis therapy, Shanghai Genomics; Liver fibrosis, Gene Networks International; Liver fibrosis, Shanghai
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Liver disease [ICD-11: DB90-BD99] | Phase 2 | [1] | |
Company |
GNI Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H11NO2
|
|||
Canonical SMILES |
CC1=CN(C(=O)C=C1)C2=CC=C(C=C2)O
|
|||
InChI |
1S/C12H11NO2/c1-9-2-7-12(15)13(8-9)10-3-5-11(14)6-4-10/h2-8,14H,1H3
|
|||
InChIKey |
NETTXQJYJRFTFS-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 851518-71-3
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Aminotransferase (AT) | Target Info | Inhibitor | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020436) | |||
REF 2 | Expansion of the clavulanic acid gene cluster: identification and in vivo functional analysis of three new genes required for biosynthesis of clavulanic acid by Streptomyces clavuligerus. J Bacteriol. 2000 Jul;182(14):4087-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.